Ebit Cambiamento Data
AbbVie USD 5.24B 1.5B 2024-12
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 4.03B 11M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
Astellas Pharma JPY -44475000000 63.86B 2024-03
AstraZeneca USD 4.2B 119M 2024-12
Bayer EUR 855M 588M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Daiichi Sankyo JPY 27.08B 72.41B 2024-03
Eli Lilly USD 5.63B 3.88B 2024-12
Exelixis USD 163.46M 27.38M 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
Incyte USD 376.26M 121.03M 2024-12
Ionis Pharmaceuticals USD -110000000 38M 2024-12
Merck USD 5.22B 339M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Novartis USD 4.86B 286M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Agios Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.